Oteracil Completed Phase 3 Trials for Gastric Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00400179A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00150670Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer